A director at Rayonier Advanced Materials Inc maiden bought 12,500 shares at 8.040USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
We recently had the opportunity to speak with Joshua Hicks, Senior Vice President of RYAM’s High Purity Cellulose (HPC) SBU. Joshua provided an overview of HPC, which is RYAM’s largest business unit and makes up 75-80% of revenue and EBITDA, highlighting market dynamics, the company’s strategy to drive value for its specialty offerings, and RYAM’s repositioning as a pure-play specialty producer. This report contains a transcript of the conversation, which can be accessed on demand. The link is a...
Downgrading Manufacturing to Market Weight Our bullish outlook (since early-November 2023) remains intact. In terms of the S&P 500 and Nasdaq 100, there are few things more bullish than indexes breaking out to all-time highs following a major correction that we had in 2022 -- but that is exactly what is happening. In last week's Compass (5/21/24) we discussed how it is a very bullish sign that there have been three upside gaps in May on the S&P 500, with all gaps left unfilled. This and the hea...
1Q24 performance ahead of expectations. RYAM reported 1Q24 results that included EPS of ($0.02) versus consensus of ($0.10) and our estimate of ($0.19). While sales of $388 million fell short of our estimate of $402 million and consensus of $430 million, tight cost controls, lower raw material and transportation costs, and improved operating efficiencies drove EBITDA of $52 million versus our estimate of $39 million and consensus of $49 million. EBITDA guidance maintained, FCF guidance increased...
Light at the end of the tunnel? As RYAM prepares to release its 1Q24 results next Wednesday, it appears that fundamentals are improving across several of its markets, with pulp prices continuing to recover from mid-2023 lows and demand from construction markets stabilizing in the wake of customer inventory drawdowns that reduced RYAM’s opportunities to sell into the market in 2023. 1Q24 comps likely to struggle, but outlook may improve. Management’s guidance for 1Q24 issued at the 4Q23 report in...
We recently hosted CEO De Lyle Bloomquist for a fireside chat. We discussed RYAM’s current business portfolio performance in 2023 and the outlook for 2024, the opportunities in biomaterials, and the progress being made in streamlining the company’s business portfolio away from commodity and low differentiation product families and businesses. This report contains a transcript of the conversation from March 7, 2024, which can be accessed on demand in our full report. Debt reduction remains top pr...
4Q23 disappoints but headwinds subsiding. RYAM reported 4Q23, which included solid revenue of $422 million, ahead of our estimate of $373 million. However, adjusted EBITDA of $37 million fell well short of Street expectations and our $48 million forecast on weaker-than-expected paperboard demand and lower-than-anticipated pulp prices. Right-sized inventory suggests modest growth. With customer channel destocking largely completed in 4Q23, RYAM’s businesses should see a more stable demand environ...
3Q23 results reflect cyclical bottom. RYAM reported 3Q23 results that included total revenue of $369 million, EBITDA of $24 million, and EPS of ($0.39), which reflected the Q/Q decline across all three measures, as previewed by company management at its Investor Day held earlier in October. 4Q23 recovery implies inflection point reached. Despite continuing softness in the company’s acetate part of the specialty cellulose portfolio, driven by weak building & construction markets and weak Y/Y pric...
Portfolio strength and market weakness. At a recently held Investor Day, RYAM management highlighted its cellulose product portfolio, the company’s biomaterials initiative, and the current state of the industry in the wake of the G-P closure announcement. RYAM also provided an update on 2023 guidance and a look at 2024 and 2027 EBITDA bridges. Asset evaluation proceeding to the next round. Following the Investor Day, RYAM announced that it engaged Houlihan Lokey as its financial advisor to explo...
We are initiating coverage of Rayonier Advanced Materials, Inc. (RYAM), a leading supplier of wood-derived products and specialty materials, such as specialty cellulosics, paperboard, and high-yield pulp, to the industrial and consumer markets. The company is currently focused on deleveraging the balance sheet and investing in the growth of higher-value biomaterial products, while improving operations and profitability of cash generative, but slower-growing, legacy operations. FCF generation in ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.